| scholarly article | Q13442814 |
| P2093 | author name string | James A Wells | |
| Alexander J Martinko | |||
| Duy P Nguyen | |||
| Zachary B Hill | |||
| P2860 | cites work | Rapid and orthogonal logic gating with a gibberellin-induced dimerization system | Q24609546 |
| CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes | Q24625361 | ||
| T cell activation | Q24658051 | ||
| Synthetic biology in mammalian cells: next generation research tools and therapeutics | Q26995293 | ||
| Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science | Q26995510 | ||
| Manipulating signaling at will: chemically-inducible dimerization (CID) techniques resolve problems in cell biology | Q27024489 | ||
| Remote control of therapeutic T cells through a small molecule-gated chimeric receptor. | Q27330599 | ||
| Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family | Q27645935 | ||
| Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteins | Q27667191 | ||
| Structural snapshots reveal distinct mechanisms of procaspase-3 and -7 activation | Q27678026 | ||
| Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis | Q27734734 | ||
| Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin | Q27860688 | ||
| Chemically controlled protein assembly: techniques and applications | Q28278197 | ||
| Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity | Q28831343 | ||
| An inhibitor of Bcl-2 family proteins induces regression of solid tumours | Q29547595 | ||
| Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression | Q29615784 | ||
| ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor | Q29616727 | ||
| Inducible apoptosis as a safety switch for adoptive cell therapy | Q29617710 | ||
| DNASU plasmid and PSI:Biology-Materials repositories: resources to accelerate biological research. | Q30355555 | ||
| Two-state selection of conformation-specific antibodies | Q33408112 | ||
| Complex transcriptional modulation with orthogonal and inducible dCas9 regulators. | Q33704483 | ||
| Chemically induced dimerization of dihydrofolate reductase by a homobifunctional dimer of methotrexate. | Q33901080 | ||
| Versatile strategy for controlling the specificity and activity of engineered T cells | Q34045831 | ||
| Split-protein systems: beyond binary protein-protein interactions | Q34070966 | ||
| Controlling Signal Transduction with Synthetic Ligands | Q34306937 | ||
| Chemical development of intracellular protein heterodimerizers | Q34340381 | ||
| Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. | Q34394101 | ||
| A humanized system for pharmacologic control of gene expression | Q34394730 | ||
| An improved single-chain Fab platform for efficient display and recombinant expression | Q34979754 | ||
| Engineering the ABA plant stress pathway for regulation of induced proximity | Q35031343 | ||
| Highly efficient Cas9-mediated transcriptional programming | Q35372727 | ||
| Structural transition in Bcl-xL and its potential association with mitochondrial calcium ion transport | Q35663795 | ||
| Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2). | Q35895004 | ||
| A High Through-put Platform for Recombinant Antibodies to Folded Proteins | Q36134059 | ||
| Factors influencing the immunogenicity of therapeutic proteins | Q36164602 | ||
| Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice | Q36473581 | ||
| Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies | Q36551673 | ||
| Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation | Q37127495 | ||
| Conditional glycosylation in eukaryotic cells using a biocompatible chemical inducer of dimerization. | Q37260166 | ||
| Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer | Q37551219 | ||
| Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. | Q38172752 | ||
| New dimension in therapeutic targeting of BCL-2 family proteins | Q38477617 | ||
| Engineered T cells: the promise and challenges of cancer immunotherapy. | Q38828829 | ||
| Rapamycin inhibiting Jurkat T cells viability through changing mRNA expression of serine/threonine protein phosphatase 2A. | Q39446920 | ||
| CAR-T's forge ahead, despite Juno deaths | Q40387330 | ||
| The activation antigen CD69. | Q40558412 | ||
| Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells | Q41411382 | ||
| An inducible caspase 9 safety switch for T-cell therapy | Q41768001 | ||
| Bio-layer interferometry for measuring kinetics of protein-protein interactions and allosteric ligand effects. | Q42018301 | ||
| A small molecule-regulated guanine nucleotide exchange factor | Q43216095 | ||
| The ORFeome Collaboration: a genome-scale human ORF-clone resource. | Q53170526 | ||
| Bcl-2 family proteins are essential for platelet survival. | Q53581386 | ||
| Non-Antibody Scaffolds as Alternative Therapeutic Agents | Q57260221 | ||
| P4510 | describes a project that uses | ggplot2 | Q326489 |
| P433 | issue | 2 | |
| P304 | page(s) | 112-117 | |
| P577 | publication date | 2017-12-04 | |
| P1433 | published in | Nature Chemical Biology | Q904026 |
| P1476 | title | Human antibody-based chemically induced dimerizers for cell therapeutic applications | |
| P478 | volume | 14 |
| Q64940285 | A chemically induced proximity system engineered from the plant auxin signaling pathway. |
| Q89492758 | Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library |
| Q97646074 | Development and Application of CRISPR/Cas in Microbial Biotechnology |
| Q98611546 | Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function |
| Q90067023 | Local delivery of bone morphogenetic protein-2 from near infrared-responsive hydrogels for bone tissue regeneration |
| Q90003530 | Multi-input chemical control of protein dimerization for programming graded cellular responses |
| Q58798742 | Next-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase Separation |
Search more.